We are live on ! Find out more
CC

Chicago Capital Portfolio holdings

AUM $4.15B
1-Year Est. Return 31.09%
This Fund
S&P 500
This Quarter Est. Return
+9.01%
1 Year Est. Return
+31.09%
3 Year Est. Return
+117.08%
5 Year Est. Return
+137.61%
10 Year Est. Return
–
AUM
$1.81B
AUM Growth
+$78.7M
Cap. Flow
-$22.3M
Cap. Flow %
-1.23%
Top 10 Hldgs %
34.83%
Holding
244
New
11
Increased
33
Reduced
78
Closed
17

Top Buys

Rank Stock Value
1
INTU icon
Intuit
INTU
+$34.1M
2
NFLX icon
Netflix
NFLX
+$17.9M
3
ASML icon
ASML
ASML
+$17.6M
4
SYK icon
Stryker
SYK
+$17.3M
5
OABI icon
OmniAb
OABI
+$12.6M

Top Sells

Rank Stock Value
1
ABMD
Abiomed Inc
ABMD
+$30.9M
2
GPN icon
Global Payments
GPN
+$29.9M
3
LGND icon
Ligand Pharmaceuticals
LGND
+$27.1M
4
SBNY
Signature Bank
SBNY
+$20.7M
5
TNDM icon
Tandem Diabetes Care
TNDM
+$6.87M

Sector Composition

Rank Sector Weight
1 Healthcare 23.73%
2 Technology 23.69%
3 Financials 16.04%
4 Communication Services 9.8%
5 Consumer Discretionary 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LIDR icon
226
AEye
LIDR
$52.8M
$52.4K ﹤0.01%
3,631
– –
SLDP icon
227
Solid Power
SLDP
$463M
$28.1K ﹤0.01%
11,075
– –
AXDX
228
DELISTED
Accelerate Diagnostics
AXDX
– –
-2,000
Closed -$30K
CME icon
229
CME Group
CME
$96.3B
– –
-1,131
Closed -$200K
COUR icon
230
Coursera
COUR
$1.52B
– –
-11,421
Closed -$123K
CVNA icon
231
Carvana
CVNA
$68.6B
– –
-403,170
Closed -$1.64M
FIS icon
232
Fidelity National Information Services
FIS
$23.1B
– –
-6,407
Closed -$484K
GH icon
233
Guardant Health
GH
$21.7B
– –
-106,252
Closed -$5.72M
LIT icon
234
Global X Lithium & Battery Tech ETF
LIT
$1.51B
– –
-3,171
Closed -$210K
PL icon
235
Planet Labs
PL
$7.3B
– –
-270,277
Closed -$1.47M
PLNT icon
236
Planet Fitness
PLNT
$4.42B
– –
-12,380
Closed -$714K
RIVN icon
237
Rivian
RIVN
$22B
– –
-9,852
Closed -$324K
ROIV icon
238
Roivant Sciences
ROIV
$24.5B
– –
-938,113
Closed -$3.02M
SMWB icon
239
Similarweb
SMWB
$628M
– –
-10,819
Closed -$63K
VTRS icon
240
Viatris
VTRS
$20.4B
– –
-10,167
Closed -$87K
LTHM
241
DELISTED
Livent Corporation
LTHM
– –
-8,076
Closed -$248K
ABMD
242
DELISTED
Abiomed Inc
ABMD
– –
-125,636
Closed -$30.9M
AMPE
243
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
– –
-369
Closed -$7K
SBNY
244
DELISTED
Signature Bank
SBNY
– –
-137,406
Closed -$20.7M
6 7 8 9
10

Similar funds

SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Chicago Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Chicago Capital held 244 positions worth $1.81B, up 4.6% from $1.73B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Chicago Capital's Q4 2022 filing shows 11 new, 33 increased, 78 reduced and 17 closed positions. Its largest new stake was OmniAb: 2,400,717 shares worth $8.64M. The largest sale was Abiomed Inc, an estimated $30.9M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Technology and Financials.

  • Chicago Capital's largest Q4 2022 buy was OmniAb: 2,400,717 shares worth $8.64M.
  • Chicago Capital added most to Intuit in Q4 2022, an estimated $34.1M increase.
  • Chicago Capital's biggest Q4 2022 reduction was Global Payments, cutting an estimated $29.9M.
  • Chicago Capital fully exited Abiomed Inc in Q4 2022, selling an estimated $30.9M.
  • Chicago Capital's ten largest holdings make up 35% of its $1.81B portfolio in Q4 2022.
  • Chicago Capital opened 11 new positions and closed 17 in Q4 2022.
  • Chicago Capital's portfolio value rose 4.6% quarter-over-quarter to $1.81B.

Based on Chicago Capital's 13F filing for Q4 2022, filed 20 Jan 2023.